These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 9209453

  • 1. Intracellular pharmacodynamics of ara-C and flowcytometric analysis of cell cycle progression in leukemia chemotherapy.
    Nakamura T, Takauji R, Kamiya K, Kawai Y, Iwasaki H, Tohyama K, Yamauchi T, Ueda T.
    Leukemia; 1997 Apr; 11 Suppl 3():548-51. PubMed ID: 9209453
    [Abstract] [Full Text] [Related]

  • 2. Modulation of the cellular metabolism of cytarabine and fludarabine by granulocyte-colony-stimulating factor during therapy of acute myelogenous leukemia.
    Gandhi V, Estey E, Du M, Nowak B, Keating MJ, Plunkett W.
    Clin Cancer Res; 1995 Feb; 1(2):169-78. PubMed ID: 9815970
    [Abstract] [Full Text] [Related]

  • 3. Influence of fludarabine on pharmacokinetics and pharmacodynamics of cytarabine: implications for a continuous infusion schedule.
    Seymour JF, Huang P, Plunkett W, Gandhi V.
    Clin Cancer Res; 1996 Apr; 2(4):653-8. PubMed ID: 9816215
    [Abstract] [Full Text] [Related]

  • 4. Paradoxical effect of cytosine arabinoside on mouse leukemia cell line L1210 cells.
    Nakayama T, Sakamoto S, Sassa S, Suzuki S, Kudo H, Nagasawa H.
    Anticancer Res; 2005 Apr; 25(1A):157-60. PubMed ID: 15816533
    [Abstract] [Full Text] [Related]

  • 5. All-trans-retinoic acid increases cytosine arabinoside cytotoxicity in HL-60 human leukemia cells in spite of decreased cellular ara-CTP accumulation.
    Freund A, Rössig C, Lanvers C, Gescher A, Hohenlöchter B, Jürgens H, Boos J.
    Ann Oncol; 1999 Mar; 10(3):335-8. PubMed ID: 10355579
    [Abstract] [Full Text] [Related]

  • 6. Saturation of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate accumulation in leukemia cells during high-dose 1-beta-D-arabinofuranosylcytosine therapy.
    Plunkett W, Liliemark JO, Adams TM, Nowak B, Estey E, Kantarjian H, Keating MJ.
    Cancer Res; 1987 Jun 01; 47(11):3005-11. PubMed ID: 3471322
    [Abstract] [Full Text] [Related]

  • 7. Characterization of tumor cell heterogeneity of a murine leukemia cell line (L1210) in response to arabinosylcytosine: quantitation using a computerized image analysis system.
    Raymakers RA, Slocum HK, Minderman H, Malmberg M, Rustum YM.
    Exp Hematol; 1993 May 01; 21(5):602-7. PubMed ID: 8513859
    [Abstract] [Full Text] [Related]

  • 8. Minimum dose of fludarabine for the maximal modulation of 1-beta-D-arabinofuranosylcytosine triphosphate in human leukemia blasts during therapy.
    Gandhi V, Estey E, Du M, Keating MJ, Plunkett W.
    Clin Cancer Res; 1997 Sep 01; 3(9):1539-45. PubMed ID: 9815841
    [Abstract] [Full Text] [Related]

  • 9. Intracellular cytosine arabinoside accumulation and cytosine arabinoside triphosphate formation in leukemic blast cells is inhibited by etoposide and teniposide.
    Ehninger G, Proksch B, Wanner T, Schuler U, Busch FW, Schmidt H, Schleyer E, Jaschonek K, Hiddemann W.
    Leukemia; 1992 Jun 01; 6(6):582-7. PubMed ID: 1602795
    [Abstract] [Full Text] [Related]

  • 10. [Studies on intracellular kinetics of ara-C triphosphate in HL-60, human leukemia cells in relation to reasonable administration of ara-C].
    Kamiya K, Uchida M, Ueda T, Nakamura T.
    Nihon Gan Chiryo Gakkai Shi; 1990 Jul 20; 25(7):1419-27. PubMed ID: 2212834
    [Abstract] [Full Text] [Related]

  • 11. 1-beta-D-arabinofuranosylcytosine metabolism and incorporation into DNA as determinants of in vivo murine tumor cell response.
    Riva CM, Rustum YM.
    Cancer Res; 1985 Dec 20; 45(12 Pt 1):6244-9. PubMed ID: 2998596
    [Abstract] [Full Text] [Related]

  • 12. Combination of hematopoietic growth factors containing IL-3 induce acute myeloid leukemia cell sensitization to cycle specific and cycle non-specific drugs.
    Tafuri A, Lemoli RM, Chen R, Gulati SC, Clarkson BD, Andreeff M.
    Leukemia; 1994 May 20; 8(5):749-57. PubMed ID: 7514244
    [Abstract] [Full Text] [Related]

  • 13. Granulocyte-macrophage colony-stimulating factor and interleukin-3 enhance the incorporation of cytosine arabinoside into the DNA of leukemic blasts and the cytotoxic effect on clonogenic cells from patients with acute myeloid leukemia.
    Hiddemann W, Kiehl M, Zühlsdorf M, Busemann C, Schleyer E, Wörmann B, Büchner T.
    Semin Oncol; 1992 Apr 20; 19(2 Suppl 4):31-7. PubMed ID: 1553573
    [Abstract] [Full Text] [Related]

  • 14. Biochemical and cytokinetic modulation of L1210 and HL-60 cells by hydroxyurea and effect on 1-beta-D-arabinofuranosylcytosine metabolism and cytotoxicity.
    Rauscher F, Cadman E.
    Cancer Res; 1983 Jun 20; 43(6):2688-93. PubMed ID: 6189585
    [Abstract] [Full Text] [Related]

  • 15. Modulation of the metabolism and pharmacokinetics of 1-beta-D-arabinofuranosylcytosine by 1-beta-D-arabinofuranosyluracil in leukemic mice.
    Chandrasekaran B, Capizzi RL, Kute TE, Morgan T, Dimling J.
    Cancer Res; 1989 Jun 15; 49(12):3259-66. PubMed ID: 2720678
    [Abstract] [Full Text] [Related]

  • 16. Methotrexate-induced changes in the levels of 1-beta-D-arabinofuranosylcytosine triphosphate in L1210 cells.
    Roberts D, Peck C, Hilliard S, Wingo W.
    Cancer Res; 1979 Oct 15; 39(10):4048-54. PubMed ID: 476642
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of ribonucleotide reductase by a new class of isoindole derivatives: drug synergism with cytarabine (Ara-C) and induction of cellular apoptosis.
    Nandy P, Lien EJ, Avramis VI.
    Anticancer Res; 1999 Oct 15; 19(3A):1625-33. PubMed ID: 10470093
    [Abstract] [Full Text] [Related]

  • 18. Characterization of a multidrug resistant human erythroleukemia cell line (K562) exhibiting spontaneous resistance to 1-beta-D-arabinofuranosylcytosine.
    Grant S, Turner A, Nelms P, Yanovich S.
    Leukemia; 1995 May 15; 9(5):808-14. PubMed ID: 7769843
    [Abstract] [Full Text] [Related]

  • 19. Enhanced chemosensitivity of clonogenic blasts from patients with acute myeloid leukemia by G-CSF, IL-3 or GM-CSF stimulation.
    te Boekhorst PA, Löwenberg B, Vlastuin M, Sonneveld P.
    Leukemia; 1993 Aug 15; 7(8):1191-8. PubMed ID: 7688839
    [Abstract] [Full Text] [Related]

  • 20. Effect of 1-beta-D-arabinofuranosylcytosine on apoptosis and differentiation in human monocytic leukemia cells (U937) expressing a c-Jun dominant-negative mutant protein (TAM67).
    Grant S, Freemerman AJ, Birrer MJ, Martin HA, Turner AJ, Szabo E, Chelliah J, Jarvis WD.
    Cell Growth Differ; 1996 May 15; 7(5):603-13. PubMed ID: 8732670
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.